Overview

A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites

Status:
Unknown status

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

Summary

This study is designed to compare the efficacy of intraperitoneal paclitaxel in combination with SOX, with SOX alone in the first-line treatment of gastric cancer with malignant ascites

Phase:

Phase 3

Details

Lead Sponsor:

Fudan University

Treatments:

Albumin-Bound Paclitaxel
Oxaliplatin
Paclitaxel
Tegafur